Separation and efficient amplification culture method for antigen specific T lymphocyte

A lymphocyte, isolation and culture technology, applied to animal cells, antibody medical components, vertebrate cells, etc., can solve the problems of low number of antigen-specific T cells, limited number and activity of T cells, and inability to achieve clinical effects, etc. To achieve the effect of improving cell killing activity, strong tumor killing activity, and increasing cell expansion multiples

Inactive Publication Date: 2015-09-30
英普乐孚生物技术(上海)有限公司
View PDF4 Cites 17 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The number of antigen-specific T cells obtained by these methods is small, which cannot achieve good clinical effects, and the T cells cultured by these methods are prone to apoptosis induced by activation, which limits the number and activity of the final T cells.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Separation and efficient amplification culture method for antigen specific T lymphocyte
  • Separation and efficient amplification culture method for antigen specific T lymphocyte
  • Separation and efficient amplification culture method for antigen specific T lymphocyte

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] Isolation and Efficient Expansion of Antigen-specific T Lymphocytes Induced by Tumor Antigen (Tumor Cell Lysate)

[0051] Step 1: Preparation of autologous tumor cell lysates

[0052] 1.1 Take the tumor tissue resected after the operation of the melanoma patient, remove the normal tissue on the tumor tissue, and rinse it with normal saline until there is no blood and no fat residue.

[0053] 1.2 Soak with 0.1% chlorhexidine (chlorhexidine) for 30 minutes, rinse with sterile saline 3 to 4 times.

[0054] 1.3 Shred the tumor tissue with sterile surgical scissors, add an appropriate amount of saline for grinding, and collect the single cell suspension after filtering through a 200-mesh mesh.

[0055] 1.4 Put the single-cell suspension into a centrifuge tube, freeze at -86°C, thaw at room temperature, repeat the freeze-thaw 3 times, and observe under the microscope until no cells survive.

[0056] 1.5 Centrifuge the single cell suspension at 3000rpm for 30min, filter the ...

Embodiment 2

[0097] Isolation and Efficient Expansion of Antigen-specific T Lymphocytes Induced by Tumor Antigen (Protein)

[0098] Step 1: The operation is the same as Step 2 of Example 1, except that the antigen added in 2.4 is not the tumor cell lysate, but the full-length protein of the tumor antigen MART-1.

[0099] Step 2: Same as Step 3 of Example 1.

[0100] Step 3: Same as Step 4 of Example 1.

[0101] Step 4: Same as Step 5 of Example 1.

[0102] Step 5: Same as Step 6 of Example 1.

Embodiment 3

[0104] Isolation and Efficient Expansion of Antigen-specific T Lymphocytes Induced by Tumor Antigen (Polypeptide)

[0105] Step 1: DC cell culture and antigen peptide loading

[0106] 1.1 Peripheral blood mononuclear cells were collected with an apheresis machine. After Ficoll separation, the cells in the middle layer were taken and washed twice with normal saline to obtain PBMCs (peripheral blood mononuclear cells).

[0107] 1.2 Take PBMC, add RPMI 1640 medium to make 5×10 6 / ml cell suspension, inoculate 3ml per well into a 6-well plate, and put it into an incubator.

[0108] After 1.32 hours, take it out, shake it to remove the supernatant cells, and leave the adherent mononuclear cells (slightly larger than other cells), add 3ml DC medium (IMP serum-free medium, containing 2% autologous plasma, 1000IU) to each well / ml GM-CSF, 1000IU / ml IL-4).

[0109] 1.4 On day 5, add DC maturation agent (final concentration 10ng / ml LPS, 50IU / ml IFN-r).

[0110] 1.5 On day 7, add MAR...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a separation and efficient amplification culture method for an antigen specific T lymphocyte. By means of the immunomagnetic bead technology and the character of an active T cell expression CD137, the antigen specific T lymphocyte is separated from a complex cell mass; then an antigen specific T lymphocyte with high tumor killing activity is obtained through in-vitro efficient amplification culture. CD137L (CD137-ligand), IL-7, IL-15 and IL-2 are added in the culturing process, so that the phenomenon that activated and induced cells are liable to apoptosis in the culturing process is avoided, the amplification time is increased, and the killing activity of the antigen specific T lymphocyte is improved.

Description

technical field [0001] The invention belongs to the technical field of cell culture, and relates to a method for separating and efficiently expanding and culturing antigen-specific T lymphocytes. Background technique [0002] Dendritic cells (dendritic cells, DC) are the professional antigen-presenting cells (antigen process cells, APCs) with the strongest function known so far, and they play an important role in inducing the body's immune response. Immunotherapy using DCs loaded with tumor antigens as a vaccine can stimulate the body to generate a specific cytotoxic T cell immune response (cytotoxic T lymphocyte, CTL) against tumor antigens. Tumor vaccines can be divided into gene-modified dendritic cell vaccines, dendritic cell vaccines loaded with tumor antigen polypeptides, dendritic cell vaccines transfected with tumor antigen mRNA or RNA, and dendritic cell vaccines sensitized with complete tumor cell antigens. Currently, antigen-loaded DC vaccines have achieved good ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/0783A61K39/00A61P35/00
Inventor 谢志明武宁崔文浩郑蓉蓉
Owner 英普乐孚生物技术(上海)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap